Highland Capital Management (Tennessee)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-31,747
Closed -$3.15M 340
2019
Q3
$3.15M Sell
31,747
-288
-0.9% -$27.4K 0.23% 114
2019
Q2
$2.96M Sell
32,035
-16,377
-34% -$1.56M 0.22% 119
2019
Q1
$4.57M Buy
48,412
+1,768
+4% +$155K 0.35% 89
2018
Q4
$2.99M Sell
46,644
-33,940
-42% -$2.51M 0.25% 113
2018
Q3
$7.21M Buy
80,584
+4,207
+6% +$372K 0.52% 52
2018
Q2
$6.07M Buy
76,377
+1,285
+2% +$107K 0.46% 57
2018
Q1
$6.7M Buy
75,092
+6,057
+9% +$581K 0.52% 55
2017
Q4
$7.2M Sell
69,035
-3,127
-4% -$353K 0.55% 54
2017
Q3
$10.5M Buy
72,162
+7,646
+12% +$1.04M 0.84% 31
2017
Q2
$8.38M Buy
64,516
+1,349
+2% +$165K 0.67% 39
2017
Q1
$7.86M Buy
63,167
+5,051
+9% +$604K 0.65% 42
2016
Q4
$6.73M Sell
58,116
-1,657
-3% -$185K 0.57% 50
2016
Q3
$6.25M Buy
59,773
+979
+2% +$106K 0.53% 60
2016
Q2
$5.8M Buy
58,794
+8,299
+16% +$858K 0.5% 63
2016
Q1
$5.05M Sell
50,495
-2,121
-4% -$218K 0.43% 75
2015
Q4
$6.3M Sell
52,616
-9,335
-15% -$1.08M 0.51% 64
2015
Q3
$6.7M Buy
61,951
+36
+0.1% +$4.47K 0.56% 47
2015
Q2
$7.17M Buy
61,915
+11,015
+22% +$1.26M 0.55% 51
2015
Q1
$5.87M Buy
50,900
+48,230
+1,806% +$5.76M 1.15% 33
2014
Q4
$299K Hold
2,670
0.06% 133
2014
Q3
$253K Sell
2,670
-340
-11% -$30.7K 0.05% 135
2014
Q2
$258K Buy
+3,010
New +$229K 0.05% 135
2014
Q1
Sell
-2,650
Closed -$224K 140
2013
Q4
$224K Buy
+2,650
New +$210K 0.04% 123

Other funds holding CELG

Highland Capital Management (Tennessee)'s CELG Position: Q4 2019 in Review

Highland Capital Management (Tennessee) sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 31,747 shares — an estimated $3.15M sold.

Highland Capital Management (Tennessee) first reported a position in CELG in Q4 2013 and held it in 23 quarters. The position peaked at $10.5M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Highland Capital Management (Tennessee) reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 31,747 Celgene Corp shares in Q4 2019, an estimated $3.15M.
  • Highland Capital Management (Tennessee) first reported a position in Celgene Corp in Q4 2013 and held it in 23 quarters.
  • Highland Capital Management (Tennessee)'s Celgene Corp position peaked at $10.5M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q4 2019, filed 5 Feb 2020.